Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting
HONG KONG, May 19, 2020 – (ACN Newswire) – Sino Biopharmaceutical Limited (HKEX: 1177), a…